$4450
$3560
The predictive genetic testing market is projected to reach US$ 4.20 billion by 2031 from US$ 1.42 billion in 2024 and to register a CAGR of 17.1% during 2025–2031.
Predictive Genetic Testing Market AnalysisKey factors driving market growth include the rising prevalence of genetic diseases, increasing awareness and acceptance of personalized medicines, and surging preference for direct-to-consumer (DTC) genetic testing. Increasing acceptance and funding for rare disease and carrier screening initiatives are likely to create ample opportunities for the predictive genetic testing market in the coming years.
Predictive Genetic Testing Market OverviewPredictive genetic testing allows the early recognition of the patient's risk of cancer, cardiovascular diseases, or neurodegenerative disorders, usually even before the appearance of symptoms. Thanks to advancements in sequencing technology, AI-based interpretation, and bioinformatics, such tests have become a key component of preventive care and personalized treatment. North America and Europe are the leading adopters due to their robust healthcare infrastructure. In contrast, APAC is unfolding quickly, driven by increasing healthcare expenditure and greater access to genomics.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Predictive Genetic Testing Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Predictive Genetic Testing Market Drivers and OpportunitiesCustomize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Predictive Genetic Testing Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Drivers:
- Rising Prevalence of Genetic Diseases: The global rise in the number of inherited and chronic genetic disorders pushes the demand for predictive genetic testing, which makes it possible to detect the condition early, carry out prevention, and improve the management of people who are at high risk.
- Increasing Awareness and Acceptance of Personalized Medicines: Understanding about precision medicine leads to the use of predictive genetic testing, which enables healthcare providers to tailor prevention, monitoring, and treatment strategies according to a patient's genetic profile.
- Growing Preference for Direct-To-Consumer (DTC) Genetic Testing: Consumers' desire to gain a better understanding of their health while enjoying the convenience of self-testing without intermediaries has empowered them to access risk information and make informed decisions about their lifestyle and healthcare.
Market Opportunities:
- Untapped Emerging Markets in Developing Countries: With the expansion of healthcare infrastructure and rising awareness, regions in the developing world offer a tremendous potential for predictive genetic testing to be the next frontier in healthcare. These areas can be reached with the help of less expensive and portable tests, creating demand for genetic screening, which has been previously neglected among these populations.
- Increasing Acceptance and Funding for Rare Disease and Carrier Screening Initiatives: An increase in government and private investments in research into rare diseases and carrier screening programs is a key factor driving the implementation of predictive genetic testing, thereby enabling the identification of diseases at an early stage and facilitating better therapy management.
- Expansion of At-Home Testing Kits: The invention and subsequent rise in the use of home diagnostic kits for predictive genetic testing are the primary ways through which people are provided with convenient and accessible options, thus leading to the adoption of such tests on a broader scale and allowing individuals to take charge of their hereditary risk factors right in their ??????homes.
The predictive genetic testing market is segmented into various categories to provide a clearer understanding of its operations, growth potential, and current trends. Below is the standard segmentation approach used in industry reports:
By Type:
- Predispositional Testing: It identifies genetically inherited risk factors that may lead to diseases over time, allowing individuals to take necessary precautions and follow a personalized medical care plan.
- Presymptomatic Testing: It is a test that detects the absence of symptoms of a specific illness in a person who genetically carries disease-causing mutations. Thus, it can be used for intervention, continuous check-ups, and making better-informed medical and lifestyle decisions.
By Disease:
- Cancer: Predictive?????? genetic testing locates mutations that are passed down from the parents and increase the risk of cancer. In this way, methods for early detection, prevention, and personalized treatment become available.
- Cardiovascular Diseases: Identifies genetic predisposition that may lead to heart diseases, thus giving a chance for early intervention, changing lifestyle habits, and risk control to avert serious cardiovascular incidents.
- Metabolic Diseases: It evaluates the hereditary risks of diseases such as diabetes and obesity, thus providing the preventive care, diet control, and personalized healthcare that are necessary.
- Other Diseases: Diseases affecting the brain, the immune system, and rare genetic disorders are included, providing the opportunity for early identification, examination, and initiation of management to enhance patients’ prognosis.
By End User:
- Hospital-Based Laboratories
- Diagnostic Laboratories
- Other End Users:
By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Market Report Scope
Predictive Genetic Testing Market Share Analysis by GeographyNorth America is expected to hold a significant market share. The rising prevalence of genetic diseases, increasing awareness and acceptance of personalized medicines, and growing preference for direct-to-consumer (DTC) genetic testing drive the market growth. Asia Pacific is expected to grow the fastest in the next few years. Emerging markets in South and Central America, the Middle East, and Africa also offer untapped opportunities for predictive genetic testing to expand.
The growth rates of the predictive genetic testing market vary by region, influenced by the recommendations of regulatory agencies and medical guidelines for predictive genetic testing. Below is a summary of market share and trends by region:
1. North America
- Market Share: Holds a significant portion of the global market
- Key Drivers: An advanced healthcare infrastructure, robust research and development, and high awareness of personalized medicine have facilitated the primary adoption of predictive genetic testing.
- Trends: Developmental advancements and genetic testing practices
2. Europe
- Market Share: Substantial share due to the increasing prevalence of pain conditions
- Key Drivers: Government-funded projects, awareness activities, and an emphasis on prevention are facilitating the complete utilization of predictive genetic testing in healthcare systems.
- Trends: Regulatory influence on market structure
3. Asia Pacific
- Market Share: Fastest-growing region with rising market shares every year
- Key Drivers: It is a rapidly evolving area, characterized by a notable increase in healthcare investments, the establishment of genetic testing facilities, and a growing awareness of personalized and preventive medicine.
- Trends: Innovations in genetic testing services
4. South and Central America
- Market Share: Growing market with steady progress
- Key Drivers: The expansion of genetic testing services, driven by increased access to healthcare, heightened awareness, and the implementation of modern diagnostic technologies, presents a region with growth potential.
- Trends: Technological developments in genetic testing
5. Middle East and Africa
- Market Share: Small market growing at a rapid pace
- Key Drivers: The development of the market is a result of the modernization of the healthcare sector, government support for genetic testing, and increasing incidences of hereditary and lifestyle diseases.
- Trends: Growth in the acceptance and awareness regarding genetic testing
High Market Density and Competition
Competition is intense due to established players such as Eurofins Scientific SE, Illumina Inc., and F. Hoffmann-La Roche Ltd. Regional and niche providers, including Exact Sciences Corp. and GeneDx, LLC, add to the competitive landscape across different regions.
This high level of competition urges companies to stand out by offering:
- Advanced products
- Value-added services such as customization and sustainable solutions
- Competitive pricing models
- Compliance with regulatory guidelines
Opportunities and Strategic Moves
- Companies are investing in research and development, driving innovation in detection technologies. These investments improve the sensitivity and specificity, addressing specific eye health issues in different regions.
- Manufacturers will likely focus on local production to cut costs and strengthen supply chains, especially in high-volume markets such as India.
- Guardant Health
- BGI Genomics
- Bio-Rad Laboratories
- ARUP Laboratories
- Invitae Corporation
- Ancestry Genomics Inc
- Progenesis
- Fulgent Genetics, Inc
- SIVOTEC BioInformatics LLC
- Gene By Gene Ltd
- Seonix Bio launches SightScore testing service for primary open-angle glaucoma. Seonix Bio announced the commercial launch of SightScore, a clinical polygenic risk score testing service for primary open-angle glaucoma (POAG).
- Proteomics International Laboratories launches PromarkerD predictive test for diabetic kidney disease. Proteomics International Laboratories officially launched its unique PromarkerD predictive test for diabetic kidney disease in Australia. PromarkerD is a clinically validated blood test that helps predict the risk of developing chronic diabetic kidney disease (DKD) in patients with type 2 diabetes up to four years before clinical symptoms appear.
The "Predictive Genetic Testing Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Predictive genetic testing market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Predictive genetic testing market trends, and market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Predictive genetic testing market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the predictive genetic testing market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America dominated the market in 2024.
Illumina, Inc, 23andMe Holding Co, F. Hoffmann-La Roche Ltd, Ambry Genetics Corp, Myriad Genetics Inc, Exact Sciences Corp, Laboratory Corp of America Holdings, Quest Diagnostics Inc, Thermo Fisher Scientific Inc., NeoGenomics Inc are among the key players operating in the market.
The rising prevalence of genetic diseases, increasing awareness and acceptance of personalized medicines, and surging preference for direct-to-consumer (DTC) genetic testing drive market growth.
The market is estimated to register a CAGR of 17.1% during the forecast period.
The predictive genetic testing market is projected to reach a value of US$4.20 billion by 2031.
The List of Companies - Predictive Genetic Testing Market
- Illumina, Inc
- 23andMe Holding Co
- F. Hoffmann-La Roche Ltd
- Ambry Genetics Corp
- Myriad Genetics Inc
- Exact Sciences Corp
- Laboratory Corp of America Holdings
- Quest Diagnostics Inc
- Thermo Fisher Scientific Inc.
- NeoGenomics Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Predictive Genetic Testing Market
Dec 2025
Prenatal Testing Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Diagnostic Type (Noninvasive and Invasive), Disease (Aneuploidy, Microdeletions, Structural Chromosomal Abnormalities, and Others), End User (Hospitals, Diagnostic Laboratories, Specialty Clinics, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Dec 2025
Joint Resurfacing Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Knee, Hip, Shoulder, Ankle, and Others), Material (Metal, Ceramic, and Others), End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America)
Dec 2025
Embolization Plugs Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Neurology, Peripheral Vascular Disease, Oncology, Urology, and Others), End User (Hospital, Ambulatory Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Dec 2025
Carrier Testing Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Medical Condition (Pulmonary Conditions, Hematological Conditions, Neurological Conditions, and Other Medical Conditions), End User (Hospital-Based Laboratories, Diagnostic Laboratories, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Dec 2025
Recombinant Albumin Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Source (Human Recombinant Albumin, Bovine Recombinant Albumin, and Others), Application (Excipient in Biotherapeutics And Vaccines, Cell Culture, Drug Delivery, Diagnostics, and Others), and End User (Pharmaceutical and Biotechnology Companies, Research Institutes, Hospitals and Diagnostic Laboratories, and Others)
Dec 2025
Predictive Genetic Testing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Predispositional Testing and Presymptomatic Testing), Disease (Cancer, Cardiovascular Diseases, Metabolic Diseases, and Other Diseases), End User (Hospital-Based Laboratories, Diagnostic Laboratories, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Dec 2025
Medical Contract Manufacturing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Full-device Manufacturing, Sub-assembly and Components, and Materials-specific Services), Device Type (IVD Devices, Diagnostic Imaging Devices, Cardiovascular Devices, Drug Delivery Devices, Orthopedic Devices, Respiratory Care Devices, Ophthalmology Devices, Surgical Devices, Diabetes Care Devices, Dental Devices, Endoscopy and Laparoscopy Devices, Gynecology and Urology Devices, Neurology Devices, Patient Assistive Devices, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Dec 2025
Bulk Lyophilization Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Lyophilization Format (Bulk Tray Lyophilization, Drum Lyophilization, Shelf Freeze-Drying, Tunnel or Conveyer Based Freeze Drying, and Hybrid Methods), Scale (Small Scale or Lab Scale, Pilot Scale, and Commercial and Industrial Scale), Service Type (Custom Process Development and Optimization, Pilot Scale and R and D Lyophilization, and Full Scale Commercial Bulk Lyophilization), and End User (Pharmaceutical and Biotechnology Companies, Research and Academic Institutes, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)